1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of starting cellular material composition on chimeric antigen receptor T‐cell expansion and characteristics. Issue 5 (11th April 2019) Authors: Elavia, Nasha; Panch, Sandhya R.; McManus, Andrew; Bikkani, Thejaswi; Szymanski, James; Highfill, Steven L.; Jin, Ping; Brudno, Jennifer; Kochenderfer, James; Stroncek, David F. Journal: Transfusion Issue: Volume 59:Issue 5(2019) Page Start: 1755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Il-6 is non-essential to murine CD19 CAR efficacy, but can mediate acute GVHD following allogeneic BMT with CAR T cell infusion. (4th November 2015) Authors: Jacoby, Elad; Qin, Haiying; Kochenderfer, James; Yang, Yinmeng; Chien, Chris; Fry, Terry Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Il-6 is non-essential to murine CD19 CAR efficacy, but can mediate acute GVHD following allogeneic BMT with CAR T cell infusion. Issue 2 (December 2015) Authors: Jacoby, Elad; Qin, Haiying; Kochenderfer, James; Yang, Yinmeng; Chien, Chris; Fry, Terry Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma. (August 2018) Authors: Salem, Dalia A.; Maric, Irina; Yuan, Constance M.; Liewehr, David J.; Venzon, David J.; Kochenderfer, James; Stetler-Stevenson, Maryalice Journal: Leukemia research Issue: Volume 71(2018) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia. Issue 1 (December 2016) Authors: Boyiadzis, Michael; Bishop, Michael; Abonour, Rafat; Anderson, Kenneth; Ansell, Stephen; Avigan, David; Barbarotta, Lisa; Barrett, Austin; Van Besien, Koen; Bergsagel, P.; Borrello, Ivan; Brody, Joshua; Brufsky, Jill; Cairo, Mitchell; Chari, Ajai; Cohen, Adam; Cortes, Jorge; Forman, Stephen; Frie... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗